Medication Summary
The goals of pharmacotherapy are to reduce morbidity and to prevent complications. Antimicrobial therapy is essential (though most cases of acute Q fever improve without intervention) to minimize risk of chronic Q fever. Prolonged antibiotic therapy is critical in managing chronic Q fever, although exact antibiotics recommended for use are in a state of flux. Consultation with an infectious disease specialist is recommended to assist in the choice of antibiotics. The best studied are combinations of doxycycline plus an additional antibiotic (eg, fluoroquinolone, rifampin, trimethoprim-sulfamethoxazole).
Patients with Q fever who are misdiagnosed with legionellosis have responded well to intravenous (IV) erythromycin, which probably is effective for pregnant patients, although no controlled trials have been performed. Some investigators use lysosomal alkalinizing agents (eg, hydroxychloroquine) for patients with chronic Q fever to increase the effectiveness of antibiotics.
Treatment of pregnant women is complicated. Infectious disease and obstetric consultations should be sought.
Antibiotics, Other
Class Summary
Antibiotic drugs are used to provide in vivo or in vitro activity against Coxiella burnetii infections . However, empiric antimicrobial therapy must be comprehensive and should cover all likely pathogens in the clinical setting.
Doxycycline is the drug of choice (DOC) in Q fever; however, in a series of pregnant patients with Q fever, trimethoprim-sulfamethoxazole (TMP-SMZ) was used with some success.[28] In the chronic setting, the addition of chloroquine to doxycycline may improve outcomes, although data are sparse.
Doxycycline (Vibramycin, Doryx, Monodox)
Doxycycline is the first-line agent for both acute and chronic Q diseases. This agent is a bacteriostatic drug that interferes with bacterial protein and cell-wall synthesis during active multiplication by binding to 30S ribosome. For severe cases, administer intravenously (IV); for outpatients, oral administration (PO) is preferred.
Ofloxacin
Ofloxacin is an alternative antibiotic to doxycycline in acute Q fever. This quinolone agent is a derivative of pyridine carboxylic acid with broad-spectrum bactericidal effect. Quinolones are effective in treating Q fever alone or when combined with doxycycline; consultation with an infectious disease specialist is recommended before its use.
Rifampin (Rifadin)
Rifampin is used to treat all forms of tuberculosis in combination with at least one other antituberculous drug. This agent inhibits RNA synthesis in bacteria by binding to the beta subunit of DNA-dependent RNA polymerase, which in turn blocks RNA transcription. Cross-resistance has only been shown with other rifamycins; combination therapy with doxycycline should be continued for chronic Q fever for at least 18 months.
Sulfamethoxazole and Trimethoprim (Bactrim, Bactrim DS, Septra DS)
Sulfamethoxazole and trimethoprim inhibits bacterial growth by inhibiting the synthesis of dihydrofolic acid. This would be a drug to use in pregnant women after consultation with the patient's obstetrician and an infectious disease specialist.
Azithromycin (Zithromax, Zmax)
Zithromax treats mild to moderate microbial infections by binding to the 50S ribosomal subunit of susceptible microorganisms and blocking dissociation of peptidyl tRNA from ribosomes, causing RNA-dependent protein synthesis to arrest. Nucleic acid synthesis, however, is not affected.
This agent concentrates in phagocytes and fibroblasts, as demonstrated by in vitro incubation techniques. In vivo studies suggest that the concentration in phagocytes may contribute to drug distribution to inflamed tissues. Plasma concentrations are very low, but tissue concentrations are much higher, giving azithromycin value in treating intracellular organisms. This drug has a long tissue half-life.
Tetracycline
Tetracycline treats susceptible both gram-positive and gram-negative bacterial infections, as well as infections caused by species of Mycoplasma, Chlamydia, and Rickettsia. This agent inhibits bacterial protein synthesis by binding with the 30S and possibly 50S ribosomal subunits of susceptible bacteria.
Chloramphenicol
Chloramphenicol is used in patients who do not tolerate tetracycline. This agent binds to the 50S bacterial ribosomal subunits and inhibits bacterial growth by inhibiting protein synthesis. Chloramphenicol is effective against gram-negative and gram-positive bacteria. In severe cases, administer intravenously (IV); for outpatients, administer orally (PO).
Ciprofloxacin (Cipro)
Ciprofloxacin is a quinolone that is effective in treating Q fever alone or when combined with doxycycline. Consultation with an infectious disease specialist is recommended before its use.
Antimalarials
Class Summary
Antimalarial agents are used for their alkalinizing action within the phagolysosomal compartment of monocytes, where C burnetii resides.
Hydroxychloroquine (Plaquenil)
Hydroxychloroquine is used in chronic Q fever with doxycycline, which is more effective. This agent results in fewer relapses than that with doxycycline and ofloxacin, and its treatment duration can be shortened. Hydroxychloroquine sulfate 200 mg is equivalent to 155 mg hydroxychloroquine base and 250 mg chloroquine phosphate.
Analgesics, Other
Class Summary
Treatment of Q fever is symptomatic and supportive. Bed rest and mild analgesic-antipyretic therapy often help to relieve the lethargy, malaise, and fever associated with this disease.
Ibuprofen (Advil, Motrin, Caldolor, I-Prin)
Ibuprofen is usually the drug of choice (DOC) to treat mild to moderate headache unless contraindicated. This agent is also one of the few nonsteroidal anti-inflammatory drugs (NSAIDs) that is indicated for reduction of fever.
Acetaminophen (Tylenol, Feverall, Mapap, Aspirin Free Anacin)
Acetaminophen is the drug of choice (DOC) for treatment of pain in documented hypersensitivity to aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and in gastrointestinal (GI) disease or with oral (PO) anticoagulants. This agent reduces fever by directly acting on hypothalamic heat-regulating centers, increasing the dissipation of body heat by vasodilation and sweating.
Salicylates
Class Summary
Acetylsalicylic agents are effective in alleviating headaches, possibly because of their inhibition of prostaglandin synthesis.
Aspirin (Anacin, Ecotrin, Bayer Aspirin Extra Strength, Bufferin)
Aspirin is used to treat mild to moderate pain and headache. This agent blocks prostaglandin synthetase action, which in turn inhibits prostaglandin synthesis and prevents formation of platelet-aggregating thromboxane A2. Aspirin enhances dissipation of heat by vasodilating peripheral vessels, causing a decrease in body temperature, as well as acts on the hypothalamus heat-regulating center to reduce fever.
Antitussives
Class Summary
Treatment of Q fever is symptomatic and supportive. Antitussives help to relieve the coughing associated with pneumonia, which is among the most common presenting symptoms. Few data on the effectiveness of expectorants outside the test tube have been reported. The prototype antitussive, codeine, was successfully used in models of chronic and induced cough, but clinical data for upper respiratory infections are limited. Existing data report the effectiveness of codeine to be somewhat equal to that of guaifenesin, dextromethorphan, or even placebo.
Dextromethorphan/guaifenesin (Mucinex DM, Robafen DM, Double Tussin DM)
Dextromethorphan is used for treatment of minor cough resulting from bronchial and throat irritation.
Benzonatate (Tessalon, Zonatuss)
Benzonatate is used for the symptomatic relief of cough. This agent suppresses cough by anesthetizing stretch receptors located in the respiratory passages, lungs, and pleura by dampening activity and reducing cough reflex.
Codeine/guaifenesin (Tussin-C, Allfen CD, ExeClear-C)
The combination of codeine and guaifenesin is used to treat minor cough resulting from bronchial and throat irritation.
Centers for Disease Control and Prevention. Emergency preparedness and response: bioterrorism agents/diseases. Available at http://www.bt.cdc.gov/agent/agentlist-category.asp. Accessed October 6, 2011.
Marrie TJ, Raoult D. Coxiella burnetii (Q fever). In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 6th ed. Philadelphia, Pa: Churchill Livingstone; 2005:2296-303.
Samuel JE, Hendrix LR. Laboratory maintenance of Coxiella burnetii. Curr Protoc Microbiol. Nov 2009;Chapter 6:Unit 6C.1. [Medline].
Raoult D, Stein A. Q fever during pregnancy: a risk for the mother, for the fetus and for the obstetrician. N Engl J Med. 1994;330:371.
Ong C, Ahmad O, Senanayake S, Buirski G, Lueck C. Optic neuritis associated with Q fever: case report and literature review. Int J Infect Dis. Sep 2010;14 Suppl 3:e269-73. [Medline].
Carcopino X, Raoult D, Bretelle F, Boubli L, Stein A. Q Fever during pregnancy: a cause of poor fetal and maternal outcome. Ann N Y Acad Sci. May 2009;1166:79-89. [Medline].
Oyston PC, Davies C. Q fever: the neglected biothreat agent. J Med Microbiol. Jan 2011;60:9-21. [Medline].
Marrie TJ, Stein A, Janigan D, Raoult D. Route of infection determines the clinical manifestations of acute Q fever. J Infect Dis. Feb 1996;173(2):484-7. [Medline].
Marrie TJ. Q fever pneumonia. Infect Dis Clin North Am. Mar 2010;24(1):27-41. [Medline].
Waag DM. Coxiella burnetii: host and bacterial responses to infection. Vaccine. Oct 16 2007;25(42):7288-95. [Medline].
Cutler SJ, Bouzid M, Cutler RR. Q fever. J Infect. Apr 2007;54(4):313-8. [Medline].
Hartzell JD, Wood-Morris RN, Martinez LJ, Trotta RF. Q fever: epidemiology, diagnosis, and treatment. Mayo Clin Proc. May 2008;83(5):574-9. [Medline].
Raoult D, Tissot-Dupont H, Foucault C, et al. Q fever 1985-1998. Clinical and epidemiologic features of 1,383 infections. Medicine (Baltimore). Mar 2000;79(2):109-23. [Medline].
World Health Organization. Report of a WHO Group of Consultants. Health aspects of chemical and biological weapons. Geneva, Switzerland: WHO Press; 1970.
Karakousis PC, Trucksis M, Dumler JS. Chronic Q fever in the United States. J Clin Microbiol. Jun 2006;44(6):2283-7. [Medline]. [Full Text].
Centers for Disease Control and Prevention. Potential for Q fever infection among travelers returning from Iraq and the Netherlands. Available at http://emergency.cdc.gov/HAN/han00313.asp. Accessed May 12, 2010.
Schimmer B, Morroy G, Dijkstra F, et al. Large ongoing Q fever outbreak in the south of The Netherlands, 2008. Euro Surveill. Jul 31 2008;13(31):[Medline]. [Full Text].
Dupuis G, Petite J, Péter O, Vouilloz M. An important outbreak of human Q fever in a Swiss Alpine valley. Int J Epidemiol. Jun 1987;16(2):282-7. [Medline].
Terheggen U, Leggat PA. Clinical manifestations of Q fever in adults and children. Travel Med Infect Dis. May 2007;5(3):159-64. [Medline].
Scola BL. Current laboratory diagnosis of Q fever. Semin Pediatr Infect Dis. Oct 2002;13(4):257-62. [Medline].
Raoult D, Houpikian P, Tissot Dupont H, et al. Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine. Arch Intern Med. Jan 25 1999;159(2):167-73. [Medline].
Healy B, Llewelyn M, Westmoreland D, Lloyd G, Brown N. The value of follow-up after acute Q fever infection. J Infect. Apr 2006;52(4):e109-12. [Medline].
Fenollar F, Raoult D. Molecular diagnosis of bloodstream infections caused by non-cultivable bacteria. Int J Antimicrob Agents. Nov 2007;30 Suppl 1:S7-15. [Medline].
Healy B, van Woerden H, Raoult D, et al. Chronic Q fever: different serological results in three countries--results of a follow-up study 6 years after a point source outbreak. Clin Infect Dis. Apr 15 2011;52(8):1013-9. [Medline].
Brouillard JE, Terriff CM, Tofan A, Garrison MW. Antibiotic selection and resistance issues with fluoroquinolones and doxycycline against bioterrorism agents. Pharmacotherapy. Jan 2006;26(1):3-14. [Medline].
Moodie CE, Thompson HA, Meltzer MI, Swerdlow DL. Prophylaxis after exposure to Coxiella burnetii. Emerg Infect Dis. Oct 2008;14(10):1558-66. [Medline]. [Full Text].
Parker NR, Barralet JH, Bell AM. Q fever. Lancet. Feb 25 2006;367(9511):679-88. [Medline].
Raoult D, Fenollar F, Stein A. Q fever during pregnancy: diagnosis, treatment, and follow-up. Arch Intern Med. Mar 25 2002;162(6):701-4. [Medline].

